General Information of the Compound
| Compound ID |
CP0181668
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine
4-[[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]methyl]morpholine
851546-84-4
CHEMBL391379
CTK3C9230
DTXSID80458181
Morpholine, 4-[[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]methyl]-
SCHEMBL5699765
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H19BrClNO2
|
||||||||||||||||||
| Molecular Weight |
396.712
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H19BrClNO2/c19-16-3-6-18(23-13-14-1-4-17(20)5-2-14)15(11-16)12-21-7-9-22-10-8-21/h1-6,11H,7-10,12-13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
JUKUHNUKMFGLIK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound